Legend Biotech(LEGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LEGN Legend Biotech

Not Yet Opened 08-06 16:00:00 EDT

19.28

+0.23

+1.21%

盘后19.30

+0.02+0.10%

19:34 EDT

High19.88	Low19.05	Vol2.07M
Open19.05	D1 Closing19.05	Amplitude4.36%
Mkt Cap3.73B	Tradable Cap1.74B	Total Shares193.44M
T/O40.05M	T/O Rate2.30%	Tradable Shares90.19M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LEGN","market":"US","secType":"STK","nameCN":"Legend Biotech","latestPrice":19.28,"timestamp":1786046400000,"preClose":19.05,"halted":0,"volume":2072955,"hourTrading":{"tag":"盘后","latestPrice":19.3,"preClose":19.28,"latestTime":"19:34 EDT","volume":546083,"amount":10528721.7307,"timestamp":1786059243420,"change":0.02,"changeRate":0.001037,"amplitude":0.0057},"delay":0,"changeRate":0.012073490813648316,"floatShares":90192700,"shares":193439800,"eps":-1.380412,"marketStatus":"Not Yet Opened","change":0.23,"latestTime":"08-06 16:00:00 EDT","open":19.05,"high":19.88,"low":19.05,"amount":40045046.18448,"amplitude":0.04357,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.380412,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1786089600000},"marketStatusCode":0,"adr":0,"adrRate":2,"listingDate":1591329600000,"exchange":"NASDAQ","adjPreClose":19.05,"preHourTrading":{"tag":"盘前","latestPrice":19.05,"preClose":19.05,"latestTime":"08:15 EDT","volume":945,"amount":18018.150569999998,"timestamp":1786018512184,"change":0,"changeRate":0,"amplitude":0.036745},"postHourTrading":{"tag":"盘后","latestPrice":19.3,"preClose":19.28,"latestTime":"19:34 EDT","volume":546083,"amount":10528721.7307,"timestamp":1786059243420,"change":0.02,"changeRate":0.001037,"amplitude":0.0057},"volumeRatio":0.873141,"impliedVol":0.636,"impliedVolPercentile":0.6773},"requestUrl":"/m/hq/s/LEGN","defaultTab":"news","newsList":[{"id":"1180866225","title":"Earning Preview: Legend Biotech this quarter’s revenue is expected to increase by 55.36%, and institutional views are positive","url":"https://stock-news.laohu8.com/highlight/detail?id=1180866225","media":"Earnings Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1180866225?lang=en_us&edition=fundamental","pubTime":"2026-08-05 00:15","pubTimestamp":1785860109,"startTime":"0","endTime":"0","summary":"Abstract Legend Biotech will report second-quarter results on August 11, 2026 Pre-MKt; consensus points to accelerating top-line momentum alongside a return toward operating profitability, with the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: Legend Biotech this quarter’s revenue is expected to increase by 55.36%, and institutional views are positive","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656302298","title":"Legend Biotech Interim CEO Alan Bash Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2656302298","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656302298?lang=en_us&edition=fundamental","pubTime":"2026-08-04 05:02","pubTimestamp":1785790953,"startTime":"0","endTime":"0","summary":"Legend Biotech interim CEO Alan Bash files initial beneficial ownership statementLegend Biotech interim CEO Alan Bash filed an initial Form 3 disclosing 30,234 ordinary shares, including 13,092 RSUs v","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL6RBBSR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4505","CANC","BK4139","LEGN","MEDI","MEMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655336101","title":"Legend Biotech (LEGN) CEO Exit Raises Questions, Is The Stock Still Cheap?","url":"https://stock-news.laohu8.com/highlight/detail?id=2655336101","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655336101?lang=en_us&edition=fundamental","pubTime":"2026-07-31 10:21","pubTimestamp":1785464509,"startTime":"0","endTime":"0","summary":"Legend Biotech (LEGN) is back in focus after CEO and board member Ying Huang, Ph.D., resigned on July 24, 2026. CARVYKTI business head Alan Bash is stepping in as Interim CEO.\nSee our latest analysis for Legend Biotech.\nLegend Biotech's share price has come under pressure despite its cell therapy focus, with the 30 day share price return down 34.04% and the 1 year total shareholder return down 51.24%, suggesting momentum has faded as investors reassess execution risk after the CEO change.\nIf...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-legn/legend-biotech/news/legend-biotech-legn-ceo-exit-raises-questions-is-the-stock-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-legn/legend-biotech/news/legend-biotech-legn-ceo-exit-raises-questions-is-the-stock-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XBI","BK4588","BK4505","MEMS","BK4139","MEDI","CANC","BK4581","LEGN","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654004836","title":"Legend Biotech to Host Investor Call on Second-quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2654004836","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654004836?lang=en_us&edition=fundamental","pubTime":"2026-07-28 20:07","pubTimestamp":1785240461,"startTime":"0","endTime":"0","summary":"Legend Biotech to host investor call on second-quarter 2026 resultsLegend Biotech scheduled an investor conference call at 8:00 a.m. ET on Aug. 11, 2026 to review second-quarter 2026 results.Live webcast access via .Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Legend Biotech Corporation published the original content used to generate this news brief on July 28, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDL4LDKKr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","MEDI","MEMS","BK4505","BK4585","BK4139","LEGN","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654210009","title":"Legend Biotech Corp : Raymond James Cuts Target Price to $58 from $86","url":"https://stock-news.laohu8.com/highlight/detail?id=2654210009","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654210009?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:34","pubTimestamp":1785238492,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nFWN43U10V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LEGN","MEMS","BK4505","BK4588","CANC","MEDI","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654003779","title":"Legend Biotech Price Target Maintained with a $65.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2654003779","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654003779?lang=en_us&edition=fundamental","pubTime":"2026-07-28 18:27","pubTimestamp":1785234420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LEGN/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654003233","title":"Buy Rating Reiterated as Strong CARVYKTI Momentum and Attractive Valuation Support Unchanged $65 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2654003233","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654003233?lang=en_us&edition=fundamental","pubTime":"2026-07-28 18:15","pubTimestamp":1785233738,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating on Legend Biotech today and set a price target of $65.00. Mitchell Kapoor has given...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-as-strong-carvykti-momentum-and-attractive-valuation-support-unchanged-65-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-as-strong-carvykti-momentum-and-attractive-valuation-support-unchanged-65-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","MEDI","BK4139","BK4585","BK4588","XBI","MEMS","LEGN","CANC","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654044945","title":"Under the Radar: Legend Stock Tumbles After CEO's Abrupt Departure","url":"https://stock-news.laohu8.com/highlight/detail?id=2654044945","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654044945?lang=en_us&edition=fundamental","pubTime":"2026-07-28 01:01","pubTimestamp":1785171660,"startTime":"0","endTime":"0","summary":"Shares of Legend Biotech fell 14% Monday after the company announced that CEO Ying Huang stepped down and left the board. Legend said in a regulatory filing that Huang's resignation was not the result of a disagreement with the company, but didn't say anything more about why he left.Huang didn't immediately respond to messages seeking comment. The board named Alan Bash-president of the unit responsible for Legend's main drug-as interim CEO while it searches for a permanent successor.Legend, based in New Jersey, sold $1.9 billion of that drug, Carvykti, last year. The therapy is made by removing a patient's own immune cells, reprogramming them in a lab to attack cancer and infusing them back into the body. Legend co-develops and sells Carvykti with Johnson & Johnson under a 2017 deal. The companies split profits equally outside China, while Legend keeps 70% of profits inside China.Oppenheimer analyst Kostas Biliouris said the leadership change was a mixed signal for investors. Huang had","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Under the Radar: Legend Stock Tumbles After CEO's Abrupt Departure","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANC","BK4139","BK4588","MEDI","BK4585","LEGN","MEMS","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654104947","title":"Legend Biotech's In Vivo CAR-T Cell Therapy Data Validates Approach, RBC Capital Markets Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2654104947","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654104947?lang=en_us&edition=fundamental","pubTime":"2026-07-27 23:32","pubTimestamp":1785166365,"startTime":"0","endTime":"0","summary":"Legend Biotech's  data from its in vivo CAR-T cell therapy program clearly validates the approach, RBC Capital Markets said in a note Monday.The investment firm said the market is not fully appreciating Legend Biotech's potential with the program, with the company giving back most of its share gains.RBC said the potential for additional follow-up data this year and the fact that in vivo's profile should enable higher peak potential could drive Legend's shares higher.The company could reach the market as soon as 2029 if they move expediently with larger phase 1 dose expansion cohorts, enabling a $3 billion opportunity in non-Hodgkin lymphoma alone, according to the note.RBC Capital Markets retained an outperform rating on the stock, but lowered its price target to $59 from $63.Shares of the company were down more than 14% in Monday trading.Price: 18.97, Change: -3.26, Percent Change: -14.65","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEMS","BK4139","BK4230","GSIB","BK4207","CAR","BK4022","XBI","LU0310800379.SGD","LU1267930573.SGD","MEDI","BK4505","LU0708994859.HKD","BK4581","BK4585","CANC","LEGN","LU0128525929.USD","LU0029864427.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654045038","title":"Legend Biotech is Maintained at Outperform by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2654045038","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654045038?lang=en_us&edition=fundamental","pubTime":"2026-07-27 22:18","pubTimestamp":1785161880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LEGN/analyst-ratings(END) Dow Jones NewswiresJuly 27, 2026 10:18 ET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654456270","title":"Legend Biotech falls -12.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654456270","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654456270?lang=en_us&edition=fundamental","pubTime":"2026-07-27 22:00","pubTimestamp":1785160811,"startTime":"0","endTime":"0","summary":"Legend Biotech (LEGN) is down -12.5%, or -$2.77 to $19.45. Published first on TheFly – the ultimate source for real-time, market-moving breaking fi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/legend-biotech-falls-12-5-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/legend-biotech-falls-12-5-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MEDI","BK4588","LEGN","BK4505","CANC","BK4585","MEMS","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654904815","title":"Legend Biotech price target lowered to $59 from $63 at RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2654904815","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654904815?lang=en_us&edition=fundamental","pubTime":"2026-07-27 21:01","pubTimestamp":1785157271,"startTime":"0","endTime":"0","summary":"RBC Capital lowered the firm’s price target on Legend Biotech (LEGN) to $59 from $63 but keeps an Outperform rating on the shares. Despite a small ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/legend-biotech-price-target-lowered-to-59-from-63-at-rbc-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/legend-biotech-price-target-lowered-to-59-from-63-at-rbc-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LEGN","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654010525","title":"RBC Cuts Price Target on Legend Biotech to $59 From $63, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2654010525","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654010525?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:26","pubTimestamp":1785155194,"startTime":"0","endTime":"0","summary":"Legend Biotech (LEGN) has an average rating of overweight and mean price target of $52.07, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XBI","LEGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654301928","title":"Legend Biotech Shares Down 3.7% Premarket; Ying Huang Steps Down as CEO and Board Member, Alan Bash Appointed Interim CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2654301928","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654301928?lang=en_us&edition=fundamental","pubTime":"2026-07-27 18:21","pubTimestamp":1785147714,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nL4N43T0PI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MEMS","BK4588","BK4505","MEDI","LEGN","CANC","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654193550","title":"Legend Biotech Names Alan Bash Interim CEO After Ying Huang Resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2654193550","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654193550?lang=en_us&edition=fundamental","pubTime":"2026-07-27 18:03","pubTimestamp":1785146636,"startTime":"0","endTime":"0","summary":"Legend Biotech names Alan Bash interim CEO after Ying Huang resignsLegend Biotech CEO Ying Huang resigned as CEO, stepped down from the board, effective July 24, 2026.Huang plans to stay on as an advi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nNDL6KM30B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","LU0096364046.USD","LU0306806265.USD","LU0985481810.HKD","LU1974910355.USD","IE00B2B36J28.USD","LU1983299246.USD","LU0823416689.USD","LU1868836757.USD","LEGN","LU2237438978.USD","LU2360032135.SGD","LU1883839398.USD","LU2133065610.SGD","IHE","FTXH","LU1323610961.USD","REGN","LU2242652126.USD","LU0321505868.SGD","LU0225284248.USD","MEDI","BMY","BK4588","LU0868494617.USD","BBH","LU2106854487.HKD","LU2362541513.USD","LU2468319806.SGD","LU1670710661.SGD","BK4585","IBBQ","LU0306807586.USD","LU1670711123.USD","MEMS","IE00BSNM7G36.USD","LU1868836591.USD","LU1093756168.USD","LU0114720955.EUR","BK4532","LU0267386448.USD","LU1670711040.USD","IBB","LU1585245621.USD","CANC","LU1430594728.SGD","LU1917777945.USD","TBXU","IE00BJT1NW94.SGD","LU0823434583.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654016077","title":"Legend Biotech Corp - Ying Huang Steps Down as CEO and Board Member; to Remain as Advisor Through August","url":"https://stock-news.laohu8.com/highlight/detail?id=2654016077","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654016077?lang=en_us&edition=fundamental","pubTime":"2026-07-27 18:00","pubTimestamp":1785146400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUA63T5Z0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4505","CANC","BK4139","MEMS","LEGN","BK4585","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654016002","title":"Legend Biotech Corp - Alan Bash Appointed Interim CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2654016002","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654016002?lang=en_us&edition=fundamental","pubTime":"2026-07-27 18:00","pubTimestamp":1785146400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUA63T5Z0:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LEGN","BK4585","CANC","MEMS","BK4505","MEDI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654016001","title":"Legend Biotech Corp - Board Initiates Search for Permanent CEO Successor","url":"https://stock-news.laohu8.com/highlight/detail?id=2654016001","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654016001?lang=en_us&edition=fundamental","pubTime":"2026-07-27 18:00","pubTimestamp":1785146400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUA63T5Z0:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MEDI","BK4588","LEGN","BK4505","CANC","MEMS","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654001600","title":"Legend Biotech Announces CEO Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2654001600","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654001600?lang=en_us&edition=fundamental","pubTime":"2026-07-27 18:00","pubTimestamp":1785146400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUA63T5Z0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEMS","BK4139","MEDI","BK4585","CANC","BK4588","BK4505","LEGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654031258","title":"Legend Biotech Shares Fall After UBS Downgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2654031258","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654031258?lang=en_us&edition=fundamental","pubTime":"2026-07-25 02:52","pubTimestamp":1784919166,"startTime":"0","endTime":"0","summary":"Legend Biotech  shares were down 4.6% in Friday trading after UBS downgraded the company's stock to neutral from buy and adjusted its price target to $28 from $49.Trading volume stood at over 984,600 shares compared with a daily average of 2.6 million.Price: 22.45, Change: -1.08, Percent Change: -4.59","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LEGN","XBI"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.legendbiotech.com","stockEarnings":[{"period":"1week","weight":0.0121},{"period":"1month","weight":-0.3035},{"period":"3month","weight":-0.3144},{"period":"6month","weight":0.1275},{"period":"1year","weight":-0.4881},{"period":"ytd","weight":-0.1132}],"compareEarnings":[{"period":"1week","weight":0.0362},{"period":"1month","weight":0.0279},{"period":"3month","weight":0.0419},{"period":"6month","weight":0.1129},{"period":"1year","weight":0.2146},{"period":"ytd","weight":0.1271}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Legend Biotech Corp is a global, clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's differentiated technology, global development and manufacturing strategy and expertise provide it with the ability to generate, test and manufacture next-generation cell therapies targeting indications with high unmet needs.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.047546},{"month":2,"riseRate":0.5,"avgChangeRate":0.01776},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.03136},{"month":4,"riseRate":0.833333,"avgChangeRate":0.112839},{"month":5,"riseRate":0.5,"avgChangeRate":0.032168},{"month":6,"riseRate":1,"avgChangeRate":0.13586},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.022064},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.041992},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.023313},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.000245},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.020911},{"month":12,"riseRate":0,"avgChangeRate":-0.105244}],"exchange":"NASDAQ","name":"Legend Biotech","nameEN":"Legend Biotech","securityTypeName":"DR","adrRate":"1:2"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Legend Biotech(LEGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Legend Biotech(LEGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Legend Biotech,LEGN,Legend Biotech股票,Legend Biotech股票老虎,Legend Biotech股票老虎国际,Legend Biotech行情,Legend Biotech股票行情,Legend Biotech股价,Legend Biotech股市,Legend Biotech股票价格,Legend Biotech股票交易,Legend Biotech股票购买,Legend Biotech股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Legend Biotech(LEGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Legend Biotech(LEGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}